Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Bobulsky Susan sold 1,195 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Bobulsky Susan (Chief Commercial Officer, MRD) sold 1,195 Adaptive Biotechnologies Corporation shares at US$27.00 for US$32,265 under a trading plan, leaving 395,794 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 1,195 shares
- Price
- US$27.00
- Value
- US$32,265
- Holding after
- 395,794 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer, MRD
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Sale | 1,195 | US$27.00 | 395,794 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Bobulsky Susan
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Bobulsky Susan · Aug 12, 2026
- Form 4 · Bobulsky Susan · Aug 3, 2026
- Form 4 · Bobulsky Susan · Jul 20, 2026
- Form 4 · Bobulsky Susan · Jul 6, 2026
- Form 4 · Rubinstein Julie · Oct 21, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026